https://www.zacks.com/stock/news/2211533/what-s-in-store-for-boston-scientific-bsx-in-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2211533
Jan 17, 2024 - Boston Scientific (BSX) is expected to have witnessed strong growth of the WATCHMAN franchise in the fourth quarter, given the FDA approval of WATCHMAN FLX Pro in September.
zc:-164476386339662944
0
https://www.zacks.com/stock/news/2213660/can-masimo-masi-run-higher-on-rising-earnings-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-2213660
Jan 22, 2024 - Masimo (MASI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
zc:-8885202545043946471
0
https://www.zacks.com/stock/news/2216520/intuitive-surgical-isrg-seeks-fda-nod-for-next-gen-da-vinci-5?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2216520
Jan 26, 2024 - Intuitive Surgical (ISRG) aims to boost its da Vinci portfolio with the addition of its next-generation da Vinci 5 multiport surgical robot.
zc:2631822466880833749
0
https://www.zacks.com/stock/news/2245969/company-news-for-mar-26-2024?cid=CS-ZC-FT-corporate_summary-2245969
Mar 26, 2024 - Companies in The News:MASI,CLFAMD,UAL
zc:8558416547877859078
0
https://www.fool.com/investing/2024/01/10/apples-win/?source=iedfolrf0000001
Jan 10, 2024 - We've also got some productivity tips for the new year.
0
fool:-5674619110658337625
0
https://www.zacks.com/stock/news/2210710/here-s-why-you-should-retain-masimo-masi-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2210710
Jan 16, 2024 - Masimo's (MASI) R&D activities raise optimism about the stock.
zc:1469515628936410621
0
https://www.zacks.com/stock/news/2212913/what-s-in-store-for-edwards-lifesciences-ew-in-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2212913
Jan 19, 2024 - Edwards Lifesciences' (EW) Q4 results are likely to reflect continued demand for its state-of-the-art HemoSphere monitoring platform and Smart Recovery portfolio in Critical Care.
zc:-1120092263613024097
0
https://www.zacks.com/stock/news/2227728/here-s-why-you-should-add-masimo-masi-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2227728
Feb 19, 2024 - Masimo's (MASI) R&D activities raise optimism about the stock.
zc:7755680708405352731
0
https://www.zacks.com/stock/news/2230943/are-medical-stocks-lagging-masimo-masi-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2230943
Feb 23, 2024 - Here is how Masimo (MASI) and CochLear Ltd. Unsponsored ADR (CHEOY) have performed compared to their sector so far this year.
zc:2149130687429443323
0
https://www.zacks.com/stock/news/2232801/masimo-masi-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2232801
Feb 27, 2024 - The headline numbers for Masimo (MASI) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zc:-3561239593185844075
0